IBM Insider Report: 2,742 RSUs Released; Shares Sold at $243.59
Rhea-AI Filing Summary
Reporting person Nicolas A. Fehring, Vice President and Controller of International Business Machines Corporation (IBM), filed a Form 4 reporting transactions on September 1-2, 2025. The filing shows vested restricted stock units (RSUs) and related share movements: 2,742 RSUs were released and converted to 2,742 shares on 09/01/2025, a sale of 1,388 shares at $243.59 on 09/01/2025, and a disposition of 400 shares on 09/02/2025.
After these transactions the reporting person beneficially owned 13,735.419 shares. The Form 4 explains the RSU grant history (original grant on 09/01/2021 with vesting tranches) and notes certain RSUs are payable in cash or common stock with future vesting dates.
Positive
- Timely and detailed disclosure of RSU releases and share transactions, satisfying Section 16 reporting requirements
- Vesting reported consistent with previously granted RSU schedule (09/01/2021 grant with staggered vesting)
Negative
- Insider sold shares (1,388 shares at $243.59 and 400 shares), reducing beneficial ownership to 13,735.419 shares
Insights
TL;DR: Insider sold a portion of vested RSUs, modestly reducing holdings; transactions appear routine rather than transformational.
The Form 4 documents standard executive equity activity: release of vested restricted stock units and subsequent market sale of a portion of the resulting shares. The sale of 1,388 shares at $243.59 and additional disposition of 400 shares reduced the reporting person’s beneficial ownership to 13,735.419 shares. This pattern—vesting followed by partial sale—is common for tax/liquidity management and does not by itself indicate a change in company fundamentals.
TL;DR: Disclosure is timely and compliant; transactions align with vesting schedule and standard reporting practice.
The filing cites an original RSU grant from 09/01/2021 with staggered vesting and notes adjustments from the Kyndryl spin-off. The disclosure that some RSUs are payable in cash or stock and that restrictions lapse on specified future dates is appropriate. The Form 4 appears complete and signed on 09/02/2025, meeting Section 16 reporting obligations for executive equity activity.